Abstract
Palliative care aims to improve the quality of life of patients and their families facing life-threatening illness. An overall treatment strategy not only includes prevention, assessment, and treatment of pain and other symptoms but also integrates psychological, social, emotional, and spiritual problems of the patient and his/her relatives. The large majority of patients being managed in palliative medicine are suffering from incurable, far-advanced, and progressive cancer. Pain is the major source of anxiety and distress at the end of life, particularly in cases of end-stage cancer. As in any stage of the disease, cancer pain treatment requires standardized guidelines adapted to the WHO’s three-step ladder of cancer pain relief (WHO 1996). Burdens and suffering of patients and relatives should be minimized, and physical, psychosocial, and spiritual symptoms must be treated even in the terminal phase.
You matter because you are you. You matter to the last moment of your life, and we will do all we can to help you not only to die peacefully, but also to live until you die.(Cicely Saunders 1976)
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adam J (1997) The last 48 hours. BMJ 315:1600–1603
Back IN, Jenkins K, Blower A et al (2001) A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med 15(4):329–336
Booth S, Wade R, Johnson M et al (2004) The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med 98(1):66–77
Cherny NI, Radbruch L, Board of the European Association for Palliative Care (2009) European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 23(7):581–593
Christakis NA, Lamont EB (2000) Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ 320:469–473
Conill C et al (1997) Symptom prevalence in the last week of life. J Pain Symptom Manage 14(6):328–331
Enting RH, Oldenmenger WH, van der Rijt CC, Wilms EB, Elfrink EJ, Elswijk I et al (2002) A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids. Cancer 94(11):3049–3056
Hall P, Schroder C, Weaver L (2002) The last 48 hours of life in long-term care: a focused chart audit. J Am Geriatr Soc 50(3):501–506
Hanks GW (1996) Morphine in cancer pain: modes of administration. Expert Working Group of the European Association for Palliative Care. BMJ 312(7034):823–826
Hardy J, Nauck F (2009) Opioids for cancer pain. In: Walsh TD, Caraceni AT, Fainsinger R, Foley KM, Glare P, Goh C, Lloyd-Williams M, Nunez Olarte J, Radbruch L (eds) Palliative medicine. Saunders Elsevier, Philadelphia, pp 1404–1411. ISBN 978-0-323-056748
Javier NS, Montagnini ML (2011) Rehabilitation of the hospice and palliative care patient. J Palliat Med 14(5):638–648
Jonen-Thielemann I (2007) Sterbephase in der Palliativmedizin. In: Aulbert E, Nauck F, Radbruch L (eds) Lehrbuch der Palliativmedizin. 2. vollst. überarb. u. erw. Aufl., Schattauer, Stuttgart, pp 176–209
Kaye P (1992) Terminal phase. In: Kaye P (ed) Notes on symptom control in hospice and palliative care. Hospice Education Institute, Essex, pp 296–300
Lawlor PG, Bruera ED (2002) Delirium in patients with advanced cancer. Hematol Oncol Clin North Am 16(3):701–714
Lichter I, Hunt E (1990) The last 48 hours of life. J Palliat Care 6(4):7–15
Lynn J et al (1997) Prognoses of seriously ill hospitalized patients on the days before death: implications for patient care and public policy. New Horiz 5:56–61
Maier R, Maier A, Müller-Busch C (2008) Outpatient opiate therapy in cancer patients during their last days of life. Schmerz 22(2):148, 150–155
Mercadante S, Radbruch L, Davies A, Poulain P, Sitte T, Perkins P, Colberg T, Camba MA (2009) A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial [In Process Citation]. Curr Med Res Opin (England) 25(11):2805–2815
Morita T, Tsunoda J, Inoue S et al (1999) Contributing factors to physical symptoms in terminally-ill cancer patients. J Pain Symptom Manage 18(5):338–346
Nauck F (1994) Der Patient in der Finalphase. In: Klaschik E, Nauck F (eds) Palliativmedizin Heute. Springer, Berlin/Heidelberg/New York/London/Paris/Tokyo/Hong Kong/Barcelona/Budapest, pp 42–50
Nauck F (2001) Symptom control in the terminal phase. Schmerz 15(5):362–369
Nauck F, Klaschik E, Ostgathe C (2000) Symptoms and symptom control during the last three days of life. Eur J Palliat Care 7(3):81–84
Nauck F, Ostgathe C, Dickerson ED (2001) A German model for methadone conversion. Am J Hosp Palliat Care 18(3):200–202
Pattison M, Romer AL (2001) Improving care through the end of life: launching a primary care clinic-based program. J Palliat Med 4(2):249–254
Potter J, Hami F, Bryan T et al (2003) Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med 17(4):310–314
Quigley C (2004) Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev (3):CD004847
Saunders C (1976) Care of the dying – 1 The problem of euthanasia. Nursing Times July 1, pp 1003–1005
Saunders C (1988) Pain and impending death. In: Wall P, Melzack R (eds) Textbook of pain. Churchill Livingstone, Edinburgh/New York, pp 624–631
Sepúlveda C, Marlin A, Yoshida T, Ulrich A (2002) Palliative care: the World Health Organization’s global perspective. J Pain Symptom Manage 24:91–96
Stiel S, Radbruch L (2014) Prognosestellung bei schwer kranken Menschen. Palliativmedizin 15(03):109–121
Stiel S, Bertram L, Neuhaus S, Nauck F, Ostgathe C, Elsner F, Radbruch L (2010) Evaluation and comparison of two prognostic scores and the physicians’ estimate of survival in terminally ill patients. Support Care Cancer 18(1):43–49
Temel J, Greer J, Muzikansky A, Gallagher E, Admane S, Jackson V, Dahlin C, Blindermann C, Jacobsen J, Pirl W, Billings A, Lynch T (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742
Thomas JR, von Gunten CF (2002) Clinical management of dyspnoea. Lancet Oncol 3(4):223–228
Twycross G, Lichter I (1998) The terminal phase. In: Doyle D, Hanks GWC, MacDonald N (eds) Oxford textbook of palliative medicine, 2nd edn. Oxford University Press, Oxford/New York/Tokyo, pp 977–990
WHO (1996) Cancer pain relief, with a guide to opioid availability, 2nd edn. World Health Organisation (WHO), Geneva
Wildiers H, Menten J (2002) Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage 23(4):310–317
Zeppetella G, Ribeiro MD (2006) Opioids for the management of breakthrough (episodic) pain in cancer patients. Cochrane Database Syst Rev (1):CD004311
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Nauck, F. (2015). The Final Phase. In: Alt-Epping, B., Nauck, F. (eds) Palliative Care in Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46202-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-46202-7_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46201-0
Online ISBN: 978-3-662-46202-7
eBook Packages: MedicineMedicine (R0)